TITLE

Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study

AUTHOR(S)
Bjerk, Sonja M.; Baker, Jason V.; Emery, Sean; Neuhaus, Jacqueline; Angus, Brian; Gordin, Fred M.; Pett, Sarah L.; Stephan, Christoph; Kunisaki, Ken M.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do not currently exist. Methods: We performed a nested, matched, case-control study among participants randomized to continuous combination antiretroviral therapy (cART) in the Strategies for Management of Antiretroviral Therapy trial. Patients who developed bacterial pneumonia (cases) and patients without bacterial pneumonia (controls) were matched 1∶1 on clinical center, smoking status, age, and baseline cART use. Baseline levels of Club Cell Secretory Protein 16 (CC16), Surfactant Protein D (SP-D), C-reactive protein (hsCRP), interleukin-6 (IL-6), and d-dimer were compared between cases and controls. Results: Cases (n = 72) and controls (n = 72) were 25.7% female, 51.4% black, 65.3% current smokers, 9.7% diabetic, 36.1% co-infected with Hepatitis B/C, and 75.0% were on cART at baseline. Median (IQR) age was 45 (41, 51) years with CD4+ count of 553 (436, 690) cells/mm3. Baseline CC16 and SP-D were similar between cases and controls, but hsCRP was significantly higher in cases than controls (2.94 µg/mL in cases vs. 1.93 µg/mL in controls; p = 0.02). IL-6 and d-dimer levels were also higher in cases compared to controls, though differences were not statistically significant (p-value 0.06 and 0.10, respectively). Conclusions: In patients with cART-treated HIV infection, higher levels of systemic inflammatory markers were associated with increased bacterial pneumonia risk, while two pulmonary-specific inflammatory biomarkers, CC16 and SP-D, were not associated with bacterial pneumonia risk.
ACCESSION #
87624427

 

Related Articles

  • Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan. Haibo Huang; Xiaonu Peng; Nakajima, Jun // BioScience Trends;Aug2013, Vol. 7 Issue 4, p172 

    Idiopathic pulmonary fibrosis is an intractable disease with a median survival time of 2 to 3 years. Serum levels of Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and surfactant protein D (SP-D) are useful biomarkers for idiopathic pulmonary fibrosis and they are widely used in...

  • Idiopathic Pleuroparenchymal Fibroelastosis is Characterized by an Elevated Serum Level of Surfactant Protein-D, but Not Krebs Von Den Lungen-6. Sato, Seidai; Hanibuchi, Masaki; Fukuya, Asami; Yabuki, Youhei; Bando, Hiroki; Yoshijima, Terumi; Goto, Hisatsugu; Ogawa, Hirohisa; Nishioka, Yasuhiko // Lung;Oct2014, Vol. 192 Issue 5, p711 

    Purpose: Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently reported rare disease entity characterized by fibrotic thickening of the pleural and subpleural parenchyma predominantly in the upper lobes in idiopathic interstitial pneumonias (IIPs). Because the clinical features of...

  • SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia. Lin-Hua Shu; Quan Lu; Li-Ying Han; Guang-Hui Dong // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 9, p11185 

    The study was aimed to evaluate the potential biomarkers from pulmonary surfactant protein D (SP-D), Krebs von den Lungen-6 (KL-6), and 56-kD a human type I protein (HTI-56) in serum and bronchoalveolar lavage fluid samples of children with Mycoplasma pneumoniae pneumonia. This retrospective...

  • Lung Surfactant Protein D (SP-D) Response and Regulation During Acute and Chronic Lung Injury. Gaunsbaek, Maria; Rasmussen, Karina; Beers, Michael; Atochina-Vasserman, Elena; Hansen, Soren // Lung;Jun2013, Vol. 191 Issue 3, p295 

    Background: Surfactant protein D (SP-D) is a collection that plays important roles in modulating host defense functions and maintaining phospholipid homeostasis in the lung. The aim of current study was to characterize comparatively the SP-D response in bronchoalveolar lavage (BAL) and serum in...

  • The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema. Chiba, Shigeki; Ohta, Hiromitsu; Abe, Kyoko; Hisata, Shu; Ohkouchi, Shinya; Hoshikawa, Yasushi; Kondo, Takashi; Ebina, Masahito // Pulmonary Medicine;2012, p1 

    The combined pulmonary fibrosis and emphysema (CPFE) was reported first in 1990, but it has been comparatively underestimated until recently. Although the diagnostic findings of both emphysematous and fibrotic regions are detectable by highresolution computed tomography (HRCT) of the chest, the...

  • Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values. AKIKI, ZEINA; FAKIH, DALIA; JOUNBLAT, RANIA; CHAMAT, SOULAIMA; WAKED, MIRNA; HOLMSKOV, UFFE; SORENSEN, GRITH L.; NADIF, RACHEL; SALAMEH, PASCALE // Experimental & Therapeutic Medicine;Mar2016, Vol. 11 Issue 3, p723 

    Biological markers can help to better identify a disease or refine its diagnosis. In the present study, the association between surfactant protein D (SP-D) and chronic obstructive pulmonary disease (COPD) was studied among subjects consulting for respiratory diseases or symptoms and was compared...

  • Surfactant Protein D Modulates HIV Infection of Both T-Cells and Dendritic Cells. Madsen, Jens; Gaiha, Gaurav D.; Palaniyar, Nades; Dong, Tao; Mitchell, Daniel A.; Clark, Howard W. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Surfactant Protein D (SP-D) is an oligomerized C-type lectin molecule with immunomodulatory properties and involvement in lung surfactant homeostasis in the respiratory tract. SP-D binds to the enveloped viruses, influenza A virus and respiratory syncytial virus and inhibits their replication in...

  • Serum pneumoproteins in tunnel construction workers. Ellingsen, Dag; Ulvestad, Bente; Bakke, Berit; Seljeflot, Ingebjørg; Barregard, Lars; Thomassen, Yngvar // International Archives of Occupational & Environmental Health;Oct2015, Vol. 88 Issue 7, p943 

    Purpose: The aim was to study inflammatory biomarkers in tunnel construction workers (TCW). Methods: Surfactant protein D (SP-D), Clara cell protein 16 (CC-16) and C-reactive protein (CRP) were studied in serum of 90 TCW and 50 referents before and at the end of an 11-day work period. Personal...

  • Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis. Hirotaka Nishikiori; Hirofumi Chiba; Shigeru Ariki; Koji Kuronuma; Mitsuo Otsuka; Masanori Shiratori; Kimiyuki Ikeda; Atsushi Watanabe; Yoshio Kuroki; Hiroki Takahashi // BMC Pulmonary Medicine;2014, Vol. 14 Issue 1, p51 

    Background Surfactant proteins SP-A and SP-D are useful biomarkers in diagnosis, monitoring, and prognosis of idiopathic pulmonary fibrosis (IPF). Despite their high structural homology, their serum concentrations often vary in IPF patients. This retrospective study aimed to investigate distinct...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics